LILLY ENDOWMENT INC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Reported portfolio value by quarter (54 quarters reported)

$108B $6.66B

Q2 13 Q1 16 Q4 18 Q3 21 Q2 24 Q3 26

$6.66B in Q2 2013 → $104B now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding	% of portfolio	Activity	Shares	Value
Eli Lilly And Company	100.0%	Trimmed 0.3%	90,066,978	$104B

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

quarter ended September 30, 2026 · filed October 19, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Eli Lilly And Company	Trimmed	−310,000	−$359M	100.0%

quarter ended June 30, 2026 · filed July 23, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Eli Lilly And Company	Trimmed	−1,520,000	−$1.82B	100.0%

quarter ended March 31, 2026 · filed April 20, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Eli Lilly And Company	Trimmed	−293,538	−$270M	100.0%

quarter ended December 31, 2025 · filed January 23, 2026

Company	Action	Shares changed	Value of change	% of portfolio
Eli Lilly And Company	Trimmed	−3,302,477	−$3.55B	100.0%

quarter ended September 30, 2025 · filed October 31, 2025

Company	Action	Shares changed	Value of change	% of portfolio
Eli Lilly And Company	Trimmed	−523,985	−$400M	100.0%

quarter ended June 30, 2025 · filed July 10, 2025

No position changes this quarter.

quarter ended March 31, 2025 · filed April 16, 2025

Company	Action	Shares changed	Value of change	% of portfolio
Eli Lilly And Company	Trimmed	−875,000	−$723M	100.0%

quarter ended December 31, 2024 · filed January 27, 2025

No position changes this quarter.

Comments